FDA Approves Pancreatic Cancer Drug Treatment After It Was Shown to Double Patient Lifespans
Article from Good News Network curated by Editor in Chief George Lundberg, MD, who notes:
The U.S. Food and Drug Administration (FDA) has approved the use of Lynparza (olaparib) for treating stage 4 pancreatic cancer. A clinical trial showed prolongation of life in many patients.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.